ÃþK¥J§Ü§íÆ{ÃÄ FDA­ã³B¤è
Á{þH´ú¸Õ¦³¤H¦Û±þ ¥~¬É¼~°Æ§@¥Î

[2019.03.07] µoªí
·s´Ú§Ü§íÆ{ÃıļQ»ó¨Ï¥Îªk¡C¡]ºô¤W¹Ï¤ù¡^

¬ü°ê­¹«~¤ÎÃĪ«ºÞ²z§½(FDA)©P¤G(5¤é)§å­ã¨Ï¥Î¤@´Ú§t¦³Ãþ¦ü¡uK¥J¡v´âÓiଦ¨¤Àªº·s´Ú¼Q»ó¦¡§Ü§íÆ{ÃÄ¡AªvÀøÃøªv©Ê§íÆ{¯g±wªÌ¡A¬°30¦~¨Ó­º¦¸¦³·sªº§íÆ{¯gÀøªk­±¥@¡C¦³ºë¯«¯f¾Ç±M®a«ü·sÃĮĪG¨ô¶V¨³³t¡A§Î®e¬°ªvÀø§íÆ{ªº­²©R¡A¦ý¥ç¦³¤H¼~¨ä®ÄªG¦³­­¡A®£¾DÀݥΡC

¦W¬°Spravatoªº¼Q»ó¾¯¥Ñ±j¥Í¤½¥q(Johnson & Johnson)¬ãµo¡A¨ä¦³®Ä¤Æ¾Ç¦¨¤ÀºÙ¬°¡u¦ã´âÓiଡv(esketamine)¡A¨ä¤Æ¾Çµ²ºc»P«UºÙ¡uK¥J¡vªº´âÓià¬(ketamine)¤¬¬°Ãè¹³¡C¦ã´âÓiବO¤@ºØ³Â¾KÃÄ¡A¦b¥¼¨¬¥H²£¥Í³Â¾K®ÄªGªº§C¾¯¶q¤U¡AÁö·|¥O¤H³´¤J²æÂ÷²{¹ê©Îºë¯««é±«ªºª¬ºA¡A¬Æ¦Ü¥X²{¤Ûı¡A¦ý¦P®É·|¥O¸£³¡ªº¯«¸g²Ó­M³sµ²«ì´_¡A§U½w¸Ñ§íÆ{¯gªº¼xª¬¡C

¬ã¨sÅã¥Ü¡A¥Ñ©ó´âÓiତΦPÃþ¤Æ¾Çª«½è°w¹ïªº¸£³¡±µ¦¬¾¹¡A»P±`¨£§Ü§íÆ{ÃĪ«¡u¦Ê¼~¸Ñ¡v(Prozac)©Î¡u¼Ö´_±o¡v(Zoloft)µ¥¡u¿ï¾Ü©Ê¦å²M¯À¦AÄá¨ú§í¨î¾¯¡v(SSRI)¤£¦P¡ASpravato¹ï©ó½w©M§íÆ{¯g¼xª¬®ÄªG§óª½±µ¨³³t¡A¨Ï¥Î¼Æ¤p®É¤º¤w¨£®Ä¡A¦ý¨ä¥LÃĪ«¥i¯à»Ý¼Æ¬P´Á¤~¦³®ÄªG¡C¨ä±`¨£°Æ§@¥Î¥]¬A·w¯t¡B°ª¦åÀ£¡B¸ÑÂ÷(dissociation)¡B·Pı¿ð¶w¡Bäú¤ß¤ÎÀYµh¡A¤@¯ë¦b¨â¤p®É¥ª¥k«K®ø°h¡C

ªAÃĻݳQºÊ¹î ¤£³\±a¨«

¤£¹LSpravatoªºÁ{þH´ú¸Õµ²ªG¦³¤Àª[¡C¨ä¤¤¨â¶µ¬ã¨sÅã¥Ü¡ASpravato»P¦w¼¢¾¯¬Û¤ñ¡A§ïµ½§íÆ{¯g¯f±¡ªº®ÄªG¸û¨Î¡F¨â¶µ¬ã¨s«hºÙ¡ASpravato»P¦w¼¢¾¯®ÄªG¤À§O¤£¤j¡C¥t¦³6¦W¯f¤H¥ÎÃīᨭ¤`¡A¨ä¤¤3¤H¦º©ó¦Û±þ¡A¦ýÃø¥H½T»{¬O§_»PÃĪ«¦³Ãö¡C

FDA©P¤G§å­ãSpravato»P¤fªA§Ü§íÆ{ÃĪ«¤@¦P¨Ï¥Î¡A¥HªvÀøÃøªv©Ê§íÆ{¯g(treatment-resistant depression)±wªÌ¡A§Y±µ¨ü¹L³Ì¤Ö¨âºØ§Ü§íÆ{ÃĪ«ªvÀø«á¤´µL®Ä¡Cµø¥G¯f±¡ÄY­«µ{«×¡AÃĪ«¥i¨C©P©Î¹j©P¬I¥Î¤@¦¸¡A¬°´Á4©P¡C°ò©ó¦w¥þºÃ¼{¡A³B¤èSpravato»Ý¨üÄY®æ­­¨î¡A¦b¦X¸ê®æªº±ÂÅvÂåÀø¾÷ºc¡A¥ÑÂåÅ@¤H­û­t³d¬IÃÄ¡A¥H«KºÊ¹î¯f¤H±¡úG¡AÃĪ«¤£³\±a¨«¡C¥t¥~¡AÃĪ«¼ÐÅÒ¤W¥²¶·¦³ÅãµÛĵ¥Ü¡Aªí©úÃĪ«±a¨ÓªºÂíÀR®ÄªG¤Î¥i¯à¾É­P¦Û±þ©ÀÀY»P¦æ¬°¡C

¨Ï¥ÎSpravatoªvÀø¨C¦¸¶O¥Î¬ù590¦Ü885¬ü¤¸¡Aµø¥G¾¯¶q¦Ó©w¡C

¼Ð·ÇÀøµ{­º¤ë¶O¥Î¬ù¬°4720¦Ü6785¬ü¤¸¡A¨ä«á·|¤U½Õ¦Ü2360¦Ü3540¬ü¤¸¡C¥Ø«e¤½¥q¤´¦b¦w±Æ¬IÃÄ°ö°Vµ¥µ{§Ç¡A¥H²Å¦X¬F©²³W©w¡A¼È¥¼ª¾¦ó®É¥¿¦¡±À¥X¡C

²{¦³ªº§íÆ{ÃĪ«¤j³¡¤À¤w¦³¼Æ¤Q¦~¾ú¥v¡A·sÃĤ[¥¼­±¥@¡C¦³¥÷°Ñ»PSpravato¶}µoªº­C¾|¤j¾Çºë¯«¯f¾Ç±Ð±Â¸t¯Ç¬ì©Ô(Gerard Sanacora)ºÙ¡ASpravato­±¥@¥O¾ã­Óºë¯«¯f¾Ç¬É³£·P¾_¾Ù¡C

¤£¹L¥L¥ç±j½Õ¡A¨Ï¥Î´âÓi଻P¬ÛÃöÃĪ«®É¥²¶·±K¤ÁºÊ¹î¡A¥H¨¾ÃĪ«³QÂà°âÀݥΡC¤Ï¹ïSpravatoÀ³¥ÎªºFDAÅU°Ý¤p²Õ¦¨­û»ô¦«(Julie Zito)»{¬°¡A¬ÛÃö¬ã¨s¤£¨¬¡AÀ³¦b¤@¯ëªÀ°Ï§@§ó¦hµû¦ô¤~±À¥XÀ³¥Î¡C(ºî¦X³ø¹D)

§ó¦h°ê»Ú­n»D
­^®æ©Ô´µ­ô¤j¾Ç¦¬¬µ¼u¥]»q
¡iºî¦X³ø¹D¡j­^°ê¦h³Bµo²{¥iºÃ¥]»q¡A¥]¬A­^°ê°ê·|¡BĬ®æÄõ®æ©Ô´µ­ô¤j¾Ç¡B®J¶ë§J´µ¤j¾Ç¡B·R¤B³ùªº¬Ó®aĬ®æÄõ»È¦æÁ`¦æ¡AµL¤H¨ü¶Ë¡C ­^°êĵ¤è¦b®æ... ¸Ô±¡
¾á¥ôªÅ­x¤k­¸¦æ­û´Á¶¡ ¬ü°Ñij­û´¿¾D¤W¯Å©Ê«I
¡i©ú³ø±M°T¡j¬ü°êÁp¨¹°Ñij­û³Á²ï²ú´¿¬OªÅ­x­º¦ì°Ñ»P§@¾Ôªº¤k©Ê­¸¦æ­û¡A¦o¬Q¤Ñ¦b°ê·|Å¥ÃÒ·|¤WÅåÃz¡A¦o´¿¾D¨ì¤@¦W¤W¯Å­x©x©Ê«I¡A¦Ó¥B¹ï­x¤è³B²z¦o¸g¾úªº... ¸Ô±¡
«ü¦h¦¸¤z¯A¤º¬F ©e¤º·ç©ÔÅX³v¼w°ê¤j¨Ï¥X¹Ò
¡i©ú³ø±M°T¡j¬ü°ê¥[±j¹ï°¨§ùù¬F©²¬IÀ£¡A¦AºM¾P¦h77¦W»P°¨§ùù¦³Ãö³sªº¤H¤hñÃÒ¡A¦Ó©e¤º·ç©Ô´N«Å¥¬ÅX³v¼w°ê¾n·í¦a¤j¨Ï¥X¹Ò¡C ©e¤º·ç©Ô¥~¥æ³¡... ¸Ô±¡
¡i©ú³ø±M°T¡j¬ü°êÁ`²Î¯S®Ô´¶¬Q¤Ñªí¥Ü¡A¦pªG´ÂÂA¥¿¦b­×´_­¸¼uµo®g³õªº³ø¹DÀò±oÃÒ¹ê¡A¥L·|¹ï´ÂÂA»â¾É¤Hª÷¥¿®¦¡u«D±`¡B«D±`¥¢±æ¡v¡A¦ý¥L¤]»¡¦¹¨Æ¥Ø«eÁÙ¨¥... ¸Ô±¡
«á²{¥N¤j®vÁF±T·sÀò¡u«Ø¿v¬É¿Õ¼ú¡v
¤é¥»«á²{¥N¥D¸q«Ø¿v¤j®vÁF±T·s©P¤G¡]5¤é¡^ºaÀò¥»¦~«×¡u°ê»Ú«Ø¿v¬É¿Õ¨©º¸¡v´¶§Q¯÷§J«Ø¿v¼ú¡Cµû¼fÆg´­¥L¥H¨ä­ì³Ð¤Î»·¨£¡A¿Ä¦XªF¦è¤è¤å¤Æ³Ð³y·s¿o«Ø¿v³]... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2019 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-9663 | Advertising Hotline Tel: (416) 673-8250